InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,598.80
(
1.03%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.33
(
-0.18%
)
Bitcoin
63,383.57
(
0.34%
)
Post# of 270
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

BC239

Send PM Follow Ignore
Followers 9
Posts 249
Boards Moderated 0
Alias Born 04/30/2010

BC239

Re: None

Monday, 01/23/2017 9:00:30 AM

Monday, January 23, 2017 9:00:30 AM

Post# of 270
Glad to find this board. I started buying in late 2015.
I think I've read everything I can on this company. I just can't find a fatal flaw. People have been using the drug for as long as 7 years through the compassionate care program in New Zealand. That's pretty amazing.
I read that 90% of the 2B trial patients have asked to stay on the drug after their 1 year test. The CEO recently met with 20 pharma companies that are following the results and have an interest in buying Innate.
Am I missing something that doesn't make this look like a big winner ?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!